FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

Novo Nordisk secures FDA approval for groundbreaking GLP-1 obesity pill, leaving Eli Lilly scrambling to catch up. What does this mean for the future of weight loss treatments?

Read More